Assistant Professor
Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida
Dr. Mohammed Gbadamosi is an Assistant Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida College of Pharmacy.
Dr. Gbadamosi completed his doctoral studies in 2021 at the University of Florida under the mentorship of Dr. Jatinder Lamba and subsequently completed his postdoctoral training as an NIH T32 Fellow under Dr. Duane Mitchell. In 2023, Dr. Gbadamosi was selected as one of thirteen individuals to receive the highly prestigious NIH Director’s Early Independence Award, enabling the launch of his research program. Currently, Dr. Gbadamosi leads a collaborative multidisciplinary research group and his research broadly leverages advanced molecular, cellular, and computational approaches to optimize the efficacy of chemotherapeutic and immuno-oncology agents. His research spans basic and translational sciences with the ultimate end goal of maximizing the efficacy of combinatorial strategies using chemotherapy and immunotherapy (chemoimmunotherapy) and developing curative chemoimmunotherapeutic treatment regimens. In addition to his research goals, Dr. Gbadamosi is also passionate about mentorship and servant leadership and one of the goals of his lab is to serve the next generation of trainees and students as a mentor, providing advocacy, opportunities, and experiences that enable success.